Frank Anderson

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands, Frank Anderson, Çharles N. Bernstein et al. · New England Journal of Medicine · 2004 · 2.2K citations · Full text

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Paul Y. Kwo, Eric Lawitz, Jonathan McCone et al. · The Lancet · 2010 · 703 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +10

Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease

Brian G. Feagan, John WD McDonald, Remo Panaccione et al. · Gastroenterology · 2013 · 327 citations · Full text

Inflammation, Rheumatology, Anti-inflammatory +7

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection

Ching‐Lung Lai, Rosmawati Mohamed, Judy Lao et al. · Gastroenterology · 2002 · 300 citations · Full text

Hepatology, Viral Hepatitis, Antiviral Drug Development +7

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

Gert Van Assche, William J. Sandborn, Brian G. Feagan et al. · Gut · 2006 · 146 citations · Full text